Nivolumab With Ipilimumab for Small Cell Lung Cancer

Video

Matthew D. Hellmann, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the CheckMate-032 study, which explored nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).

Recent Videos
1 KOL is featured in this series.
Related Content